Crane Harbor Acquisition Corp. II (CRANU) 股票分析
金融服务Crane Harbor Acquisition Corp. II
$10.25
$-0.10 (-0.97%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
Crane Harbor Acquisition Corp. II operates as a shell company within the Financial Services sector, specifically categorized under Shell Companies, with a primary business focus on executing a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and currently does not have significant operational activities beyond its intent to effect a business combination. Regarding its scale, specific market capitalization and annual revenue figures are not available for this entity, and the number of employees is listed as N/A. The absence of reported market cap and revenue data indicates that the company is in a pre-business combination stage where traditional valuation metrics based on operational performance have not yet been established. This structural position is typical for special purpose acquisition companies (SPACs) or shell companies awaiting a target, meaning the current financial scale reflects a transitional state rather than an established operating business with defined market share or revenue streams.
财务健康
The company reports a net income of $663,848 for the trailing twelve months (TTM), while revenue and EBITDA figures are listed as N/A, indicating that the reported net income likely stems from non-operating income or specific transaction-related items rather than core business profitability. Since revenue data is unavailable, the gap between revenue and net income cannot be analyzed to determine the cost structure of operational activities, as the company lacks significant operations to generate a traditional revenue stream. Similarly, free cash flow is listed as N/A, which suggests the company does not have positive cash flow from operations to support capital expenditures or dividend payments at this stage, relying instead on its existing cash reserves for liquidity management. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which reflects the lack of significant sales and operating activities necessary to calculate meaningful margins for an active business. In terms of balance sheet leverage, the company holds $117,045 in cash against $158,845 in debt, resulting in a debt-to-equity ratio that is not applicable or listed, though the negative price-to-book ratio of -38.30 further underscores the speculative nature of the equity valuation rather than asset backing. The current ratio stands at 17.87, a figure that indicates an extremely high level of short-term liquidity relative to current liabilities, suggesting the company is not under immediate pressure to meet its financial obligations despite the debt presence. Return on Equity and Return on Assets are both listed as N/A, which reveals that management effectiveness in generating returns cannot be measured using standard operating metrics until a business combination is consummated and revenue-generating operations commence.
估值评估
The trailing P/E ratio and forward P/E ratio are both listed as N/A, implying that earnings per share do not exist in a traditional sense due to the lack of significant operations, making the comparison between trailing and forward expectations impossible in the conventional sense of earnings trajectory. The price-to-book ratio is reported as -38.30, a negative figure that indicates the market price is significantly below the book value or reflects the accounting treatment of a shell company where book value does not correlate with operational asset value. The price-to-sales ratio and EV/EBITDA are also listed as N/A, suggesting that these alternative valuation metrics are not applicable until the company completes a merger and establishes a sales base. In terms of price metrics, the 52-week high is $11.11 and the 52-week low is $10.04, meaning the stock trades within a narrow range defined by these boundaries, with the current price position relative to this range dependent on the real-time market price which fluctuates but remains bounded by these extremes. The beta value is listed as N/A, which means there is no historical volatility data available to quantify the stock's price sensitivity relative to the broader market, a common characteristic for newly incorporated entities or those without significant trading history.
Growth & Income
Revenue growth and earnings growth rates are both listed as N/A, indicating that there is no historical data to compare year-over-year performance, as the company was incorporated in 2025 and has not yet achieved a sustained period of business operations. Since the company does not pay dividends, the dividend yield and payout ratio are N/A, reflecting a strategy where earnings are not distributed to shareholders but are instead retained or utilized for the purpose of facilitating a future business combination. This reinvestment profile is standard for shell companies, as the primary objective is capital preservation and deployment into a target business rather than income distribution. Consequently, the overall growth and income profile is characterized by a complete absence of operational growth metrics and dividend income, with the company's value proposition relying entirely on the potential upside of a future merger rather than current financial performance or cash yield.
同行比较
Crane Harbor Acquisition Corp. II (CRANU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| Crane Harbor Acquisition Corp. II | CRANU | N/A | N/A |
| Twenty One Capital, Inc. | XXI | $2.49B | N/A |
| Churchill Capital Corp X | CCCX | $711.00M | N/A |
| Drugs Made In America Acquisition II Corp. | DMII | $641.46M | 77.5 |
壳公司行业平均市盈率为82.8倍。Crane Harbor Acquisition Corp. II的市盈率为N/A。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关壳公司股票
Twenty One Capital, Inc.
$2.49B
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$641.46M
BCSSBain Capital GSS Investment Corp.
$595.68M
EVACEQV Ventures Acquisition Corp. II
$594.41M
CEPFCantor Equity Partners IV, Inc.
$591.50M
金融服务热门股票
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
关于Crane Harbor Acquisition Corp. II
Crane Harbor Acquisition Corp. II does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Philadelphia, Pennsylvania.
公司简介以英文显示。
访问官网 →